- From: <Kerstin.L.Forsberg@astrazeneca.com>
- Date: Wed, 11 Oct 2006 21:02:52 +0200
- To: public-semweb-lifesci@w3.org
Dear all, in our F2F meeting last week the topic "OWL vs. RDF" was mentioned briefly a couple of times. And as I understand it; Alan had a strong opinion favouring OWL, Dick argued for all RDF and was Don puzzled as me. Would be great to have some short statements from you as guidance on this topic in discussion with colleagues here at AstraZeneca. Kind regards Kerstin Forsberg AstraZeneca
Received on Wednesday, 11 October 2006 19:02:18 UTC